APA (7th ed.) Citation

Muley, T., Warth, A., Schneider, M., Dienemann, H., Meister, M., & Herth, F. (2018). The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC). Lung cancer, 120, . https://doi.org/10.1016/j.lungcan.2018.03.015

Chicago Style (17th ed.) Citation

Muley, Thomas, Arne Warth, Marc Schneider, Hendrik Dienemann, Michael Meister, and Felix Herth. "The Combination of the Blood Based Tumor Biomarkers Cytokeratin 19 Fragments (CYFRA 21-1) and Carcinoembryonic Antigen (CEA) as a Potential Predictor of Benefit from Adjuvant Chemotherapy in Early Stage Squamous Cell Carcinoma of the Lung (SCC)." Lung Cancer 120 (2018). https://doi.org/10.1016/j.lungcan.2018.03.015.

MLA (9th ed.) Citation

Muley, Thomas, et al. "The Combination of the Blood Based Tumor Biomarkers Cytokeratin 19 Fragments (CYFRA 21-1) and Carcinoembryonic Antigen (CEA) as a Potential Predictor of Benefit from Adjuvant Chemotherapy in Early Stage Squamous Cell Carcinoma of the Lung (SCC)." Lung Cancer, vol. 120, 2018, https://doi.org/10.1016/j.lungcan.2018.03.015.